Kaletra

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A multitude of rheumatologic manifestations have been associated with HIV infection and protease inhibitors use. We describe two… (More)
  • figure 1
Is this relevant?
2013
2013
We report the first known case of iatrogenic cushingoid features following orbital floor triamcinolone, a synthetic… (More)
Is this relevant?
2010
2010
Kaletra (Abott Laboratories) is a co-formulated medication used in the treatment of HIV-1-infected children, and it contains the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
OBJECTIVE To characterize total body bone mineral content (BMC) and total body and spinal bone mineral density (BMD) in… (More)
Is this relevant?
2009
2009
BACKGROUND Nucleoside reverse-transcriptase inhibitor (NRTI)-related mitochondrial toxicity has been suggested as a key factor in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2004
Review
2004
Antiretroviral treatment of HIV-infected pregnant women is widely used to prevent mother-to-child HIV transmission and as primary… (More)
Is this relevant?
2004
2004
PURPOSE We have analyzed retrospectively the evolution of metabolic parameters in a cohort of 159 HIV-infected patients taking a… (More)
Is this relevant?
2003
2003
With the advent of highly active antiretroviral therapy (HAART), HIV positivity is no longer a contraindication for liver… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2002
2002
BACKGROUND Lopinavir/ritonavir (Kaletra) is the latest available protease inhibitor (PI). It has shown greater potency than the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The association of genotypic changes in human immunodeficiency virus (HIV) protease with reduced in vitro susceptibility to the… (More)
Is this relevant?